SCHEMBL23501262

SCHEMBL23501262

COc1cc(-c2cnn(C)c2)cn2ncc(NC(=O)c3ccccc3)c12

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 3/20 0.47
RET P07949 5/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
MAPK1 P28482 2/20 0.43
KDM4E B2RXH2 1/20 0.43
HSD17B10 Q99714 1/20 0.43
AAK1 Q2M2I8 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
MAPT P10636 1/20 0.42
AHR P35869 1/20 0.42
IRAK4 Q9NWZ3 2/20 0.42
AURKB Q96GD4 2/20 0.42
ALDH1A1 P00352 1/20 0.42
AURKA O14965 1/20 0.42
KIT P10721 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23501191 0.86 HDAC1 (0.46) CSF1RRETHDAC1IRAK4AURKB
SCHEMBL23501195 0.86 CSF1R (0.43) CSF1RRETHDAC1AURKBAURKA
SCHEMBL23501427 0.85 PIK3CG (0.48) RETAAK1
SCHEMBL23501308 0.83 ERN1 (0.44) RETAAK1
SCHEMBL23501135 0.82 RET (0.40) CSF1RRETAAK1IRAK4
SCHEMBL23501235 0.82 HDAC1 (0.49) MEN1KMT2AMAPK1KDM4EHSD17B10
SCHEMBL23501274 0.81 DYRK1A (0.48) RETKDM4E
SCHEMBL1907100 0.79 RET (0.43) RETAURKBKIT
SCHEMBL1907482 0.78 RET (0.49) RETMAPK1SMN1; SMN2AURKBKIT
SCHEMBL1901010 0.77 ERN1 (0.48) RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112939967-B Pyrazolo [1,5-a ] pyridine compound, and preparation method and application thereof 深圳众格生物科技有限公司 2024-08-27 CN disclosed
CN-114787161-B Pyrazolo [1,5-a ] pyridine compound, and preparation method and application thereof 深圳众格生物科技有限公司 2024-08-02 CN disclosed
US-20230219979-A1 PYRAZOLO[1,5-a]PYRIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF SHENZHEN ZHONGGE BIOLOGICAL TECHNOLOGY CO., LTD. (CN) 2023-07-13 US disclosed
US-20230219979-A1 PYRAZOLO[1,5-a]PYRIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF SHENZHEN ZHONGGE BIOLOGICAL TECHNOLOGY CO., LTD. (CN) 2023-07-13 US disclosed
EP-4074710-A1 PYRAZOLO[1,5-A]PYRIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Shenzhen Zhongge Biological Technology Co., Ltd (CN) 2022-10-19 EP disclosed
CN-114787161-A Pyrazolo [1,5-a ] pyridine compound and preparation method and application thereof 深圳众格生物科技有限公司 2022-07-22 CN disclosed
WO-2021115457-A9 PYRAZOLO[1,5-A]PYRIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 深圳众格生物科技有限公司 2022-05-19 WO disclosed
WO-2021115457-A1 PYRAZOLO[1,5-A]PYRIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 深圳晶泰科技有限公司 2021-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219979-A1 PYRAZOLO[1,5-a]PYRIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF RET, GRK4, RIN1 CSF1R 667/4885RET 1/4885MEN1 830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.